Patients With Cerebral Microbleeds Are More Likely to Have Poor Collaterals at the Time of Mechanical ThrombectomySTROKEIF8.92024-02-010PRE
Effect of Antihypertensives by Class on Cerebral Small Vessel Disease: A Post Hoc Analysis of SPRINT-MINDSTROKEIF8.92022-08-017OA
Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamideCELL REPORTS MEDICINEIF10.62022-06-0110OAAI
Statin Usage Increases White Matter Hyperintensities: A Post-hoc Analysis Of SPRINT-MINDSTROKEIF8.92022-02-011PRE
Effect Of Antihypertensives By Class On Cerebral Small Vessel Disease: A Post-hoc Analysis Of SPRINT-MINDSTROKEIF8.92022-02-010PRE
High-throughput metabolite profiling: identification of plasma taurine as a potential biomarker of functional outcome after aneurysmal subarachnoid hemorrhageJOURNAL OF NEUROSURGERYIF3.62020-12-0117OA
Time-dependent, dynamic prediction of fatty acid-binding protein 4, Galectin-3, and soluble ST2 measurement with poor outcome after acute strokeINTERNATIONAL JOURNAL OF STROKEIF8.72020-11-0910OAAI
Uric Acid and Gluconic Acid as Predictors of Hyperglycemia and Cytotoxic Injury after StrokeTRANSLATIONAL STROKE RESEARCHIF4.32020-10-1733OAAI
Intermittent CSF drainage and rapid EVD weaning approach after subarachnoid hemorrhage: association with fewer VP shunts and shorter length of stayJOURNAL OF NEUROSURGERYIF3.62020-05-0153OAAI
Elevated miR-9 in Cerebrospinal Fluid Is Associated with Poor Functional Outcome After Subarachnoid HemorrhageTRANSLATIONAL STROKE RESEARCHIF4.32020-04-0417PREAI
Soluble ST2 links inflammation to outcome after subarachnoid hemorrhageANNALS OF NEUROLOGYIF7.72019-07-3020OAAI
High Throughput Metabolite Profiling Identifies Plasma Anandamide as a Biomarker of Functional Outcome After Aneurysmal Subarachnoid HemorrhageNEUROSURGERYIF3.92017-09-010PREAI
Soluble ST2 predicts outcome and hemorrhagic transformation after acute strokeANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGYIF3.92017-07-0538OAAI